• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Screening and linkage to care for hepatitis C among inpatients in Georgia's national hospital screening program.在佐治亚州国家医院筛查计划中对住院患者进行丙型肝炎的筛查和链接到护理。
Prev Med. 2020 Sep;138:106153. doi: 10.1016/j.ypmed.2020.106153. Epub 2020 May 27.
2
Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.格鲁吉亚消除丙型肝炎计划的进展与挑战
J Hepatol. 2020 Apr;72(4):680-687. doi: 10.1016/j.jhep.2019.11.019. Epub 2019 Dec 4.
3
Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination.2015 年格鲁吉亚丙型肝炎流行状况和危险因素:为消除工作设定基线。
BMC Public Health. 2019 May 10;19(Suppl 3):480. doi: 10.1186/s12889-019-6784-3.
4
Hepatitis C care cascade among patients with and without tuberculosis: Nationwide observational cohort study in the country of Georgia, 2015-2020.格鲁吉亚 2015-2020 年全国观察性队列研究:有和无结核病患者丙型肝炎护理链。
PLoS Med. 2023 May 4;20(5):e1004121. doi: 10.1371/journal.pmed.1004121. eCollection 2023 May.
5
Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia.格鲁吉亚全国丙型肝炎消除规划中接受索磷布韦为基础联合治疗的慢性丙型肝炎患者的治疗结局。
BMC Infect Dis. 2020 Jan 10;20(1):30. doi: 10.1186/s12879-019-4741-5.
6
An evaluation of the hepatitis C testing, care and treatment program in the country of Georgia's corrections system, December 2013 - April 2015.2013 年 12 月至 2015 年 4 月对格鲁吉亚惩教系统丙型肝炎检测、护理和治疗方案的评估。
BMC Public Health. 2019 May 10;19(Suppl 3):466. doi: 10.1186/s12889-019-6783-4.
7
Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs - Georgia, 2018.2018 年佐治亚州注射吸毒者丙型肝炎病毒感染检测和治疗进展。
MMWR Morb Mortal Wkly Rep. 2019 Jul 26;68(29):637-641. doi: 10.15585/mmwr.mm6829a2.
8
Lessons Learned From Global Hepatitis C Elimination Programs.从全球丙型肝炎消除计划中吸取的经验教训。
J Infect Dis. 2024 May 8;229(Supplement_3):S334-S341. doi: 10.1093/infdis/jiad198.
9
Three Years of Progress Toward Achieving Hepatitis C Elimination in the Country of Georgia, April 2015-March 2018.《格鲁吉亚实现丙型肝炎消除目标的三年进展,2015 年 4 月至 2018 年 3 月》。
Clin Infect Dis. 2020 Aug 22;71(5):1263-1268. doi: 10.1093/cid/ciz956.
10
The impact of COVID-19 pandemic on the 2020 hepatitis C cascade of care in the Republic of Georgia.COVID-19 大流行对格鲁吉亚共和国 2020 年丙型肝炎关怀链的影响。
Public Health. 2022 Apr;205:182-186. doi: 10.1016/j.puhe.2022.01.040. Epub 2022 Feb 9.

引用本文的文献

1
Temporal trends in hepatitis C incidence among people tested more than once in Georgia, 2017-23: a nationwide, retrospective cohort.2017 - 2023年佐治亚州多次接受检测人群中丙型肝炎发病率的时间趋势:一项全国性回顾性队列研究
Lancet Gastroenterol Hepatol. 2025 Sep;10(9):831-841. doi: 10.1016/S2468-1253(25)00124-4. Epub 2025 Jul 10.
2
Hepatitis C virus attributable liver cancer in the country of Georgia, 2015-2019: a case-control study.2015-2019 年格鲁吉亚丙型肝炎病毒相关肝癌:一项病例对照研究。
BMC Infect Dis. 2024 Sep 27;24(1):1045. doi: 10.1186/s12879-024-09916-7.
3
Evaluation of alcohol use behavior among patients cured through HCV elimination program in Georgia.评估格鲁吉亚丙型肝炎消除计划治愈患者的饮酒行为。
BMC Res Notes. 2024 Jun 10;17(1):160. doi: 10.1186/s13104-024-06814-8.
4
Hepatitis C care cascade among patients with and without tuberculosis: Nationwide observational cohort study in the country of Georgia, 2015-2020.格鲁吉亚 2015-2020 年全国观察性队列研究:有和无结核病患者丙型肝炎护理链。
PLoS Med. 2023 May 4;20(5):e1004121. doi: 10.1371/journal.pmed.1004121. eCollection 2023 May.
5
Nationwide Hepatitis C Serosurvey and Progress Towards Hepatitis C Virus Elimination in the Country of Georgia, 2021.2021 年格鲁吉亚全国丙型肝炎血清学调查及消除丙型肝炎病毒进展。
J Infect Dis. 2023 Sep 15;228(6):684-693. doi: 10.1093/infdis/jiad064. Epub 2023 Mar 18.
6
Management of in- and out-of-hospital screening for hepatitis C.院内和院外丙型肝炎筛查管理。
Front Public Health. 2023 Jan 25;10:984810. doi: 10.3389/fpubh.2022.984810. eCollection 2022.
7
Screening for hepatitis C in an outpatient endoscopy unit.门诊内镜检查科室丙型肝炎筛查
Can Liver J. 2021 Aug 9;4(3):311-316. doi: 10.3138/canlivj-2020-0038. eCollection 2021 Summer.

本文引用的文献

1
Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination.2015 年格鲁吉亚丙型肝炎流行状况和危险因素:为消除工作设定基线。
BMC Public Health. 2019 May 10;19(Suppl 3):480. doi: 10.1186/s12889-019-6784-3.
2
Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.格鲁吉亚消除丙型肝炎计划的进展与挑战
J Hepatol. 2020 Apr;72(4):680-687. doi: 10.1016/j.jhep.2019.11.019. Epub 2019 Dec 4.
3
Evaluation of a hepatitis C clinical care coordination programme's effect on treatment initiation and cure: A surveillance-based propensity score matching approach.丙型肝炎临床护理协调项目对治疗启动和治愈效果的评估:基于监测的倾向评分匹配方法。
J Viral Hepat. 2018 Nov;25(11):1236-1243. doi: 10.1111/jvh.12929. Epub 2018 May 24.
4
The Role of Screening and Treatment in National Progress Toward Hepatitis C Elimination - Georgia, 2015-2016.筛查与治疗在格鲁吉亚迈向消除丙型肝炎国家进程中的作用 - 2015 - 2016年
MMWR Morb Mortal Wkly Rep. 2017 Jul 28;66(29):773-776. doi: 10.15585/mmwr.mm6629a2.
5
HCV elimination - lessons learned from a small Eurasian country, Georgia.丙型肝炎病毒消除——从一个欧亚小国格鲁吉亚学到的经验教训。
Nat Rev Gastroenterol Hepatol. 2017 Jul 26;14(8):447-448. doi: 10.1038/nrgastro.2017.100.
6
National Progress Toward Hepatitis C Elimination - Georgia, 2015-2016.国家迈向消除丙型肝炎的进展 - 乔治亚州,2015-2016 年。
MMWR Morb Mortal Wkly Rep. 2016 Oct 21;65(41):1132-1135. doi: 10.15585/mmwr.mm6541a2.
7
Launch of a Nationwide Hepatitis C Elimination Program--Georgia, April 2015.2015年4月,格鲁吉亚启动全国丙型肝炎消除计划
MMWR Morb Mortal Wkly Rep. 2015 Jul 24;64(28):753-7. doi: 10.15585/mmwr.mm6428a2.
8
Health and treatment priorities in patients with multimorbidity: report on a workshop from the European General Practice Network meeting 'Research on multimorbidity in general practice'.患有多种疾病患者的健康和治疗重点:欧洲全科医学网络会议“全科医学中多种疾病的研究”的一个研讨会报告。
Eur J Gen Pract. 2010 Mar;16(1):51-4. doi: 10.3109/13814780903580307.

在佐治亚州国家医院筛查计划中对住院患者进行丙型肝炎的筛查和链接到护理。

Screening and linkage to care for hepatitis C among inpatients in Georgia's national hospital screening program.

机构信息

Centers for Disease Control and Prevention, Division of Viral Hepatitis, National Center for HIV, Hepatitis, STD&TB Prevention, Atlanta, USA.

Centers for Disease Control and Prevention, Division of Viral Hepatitis, National Center for HIV, Hepatitis, STD&TB Prevention, Atlanta, USA.

出版信息

Prev Med. 2020 Sep;138:106153. doi: 10.1016/j.ypmed.2020.106153. Epub 2020 May 27.

DOI:10.1016/j.ypmed.2020.106153
PMID:32473265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7440391/
Abstract

The country of Georgia initiated an ambitious national hepatitis C elimination program. To facilitate elimination, a national hospital hepatitis C screening program was launched in November 2016, offering all inpatients screening for HCV infection. This analysis assesses the effectiveness of the first year of the screening program to identify HCV-infected persons and link them to care. Data from Georgia's electronic Health Management Information System and ELIMINATION-C treatment database were analyzed for patients aged ≥18 years hospitalized from November 1, 2016 to October 31, 2017. We described patient characteristics and screening results and compared linked-to-care patients to those not linked to care, defined as having a test for viremia following an HCV antibody (anti-HCV) positive hospital screening. Of 291,975 adult inpatients, 252,848 (86.6%) were screened. Of them, 4.9% tested positive, with a high of 17.4% among males aged 40-49. Overall, 19.8% of anti-HCV+ patients were linked to care, which differed by sex (20.6% for males vs. 18.4% for females; p = .019), age (23.9% for age 50-59 years vs. 10.7% for age ≥ 70 years; p < .0001), and length of hospitalization (21.8% among patients hospitalized for 1 day vs. 16.1% for those hospitalized 11+ days; p = .023). Redundant screening is a challenge; 15.6% of patients were screened multiple times and 27.6% of anti-HCV+ patients had a prior viremia test. This evaluation demonstrates that hospital-based screening programs can identify large numbers of anti-HCV+ persons, supporting hepatitis C elimination. However, low linkage-to-care rates underscore the need for screening programs to be coupled with effective linkage strategies.

摘要

格鲁吉亚启动了一项雄心勃勃的全国丙型肝炎消除计划。为了促进消除,2016 年 11 月启动了一项全国性的医院丙型肝炎筛查计划,为所有住院患者提供丙型肝炎感染筛查。本分析评估了该筛查计划在第一年识别丙型肝炎感染患者并将其与治疗联系起来的效果。从格鲁吉亚的电子健康管理信息系统和 ELIMINATION-C 治疗数据库中分析了 2016 年 11 月 1 日至 2017 年 10 月 31 日期间年龄≥18 岁的住院患者的数据。我们描述了患者特征和筛查结果,并将与治疗相关的患者与未与治疗相关的患者进行了比较,后者定义为丙型肝炎抗体(抗-HCV)阳性医院筛查后进行病毒血症检测。在 291975 名成年住院患者中,有 252848 名(86.6%)接受了筛查。其中,4.9%的检测结果呈阳性,40-49 岁男性的阳性率最高,为 17.4%。总体而言,19.8%的抗-HCV+患者与治疗相关,这与性别(男性为 20.6%,女性为 18.4%;p=0.019)、年龄(50-59 岁年龄组为 23.9%,≥70 岁年龄组为 10.7%;p<0.0001)和住院时间(住院 1 天的患者为 21.8%,住院 11 天以上的患者为 16.1%;p=0.023)有关。重复筛查是一个挑战;15.6%的患者接受了多次筛查,27.6%的抗-HCV+患者之前进行过病毒血症检测。本评估表明,基于医院的筛查计划可以识别大量抗-HCV+人群,支持丙型肝炎消除。然而,低的与治疗相关的比例突出表明,筛查计划需要与有效的联系策略相结合。